SkinHealth Systems Inc. SKIN
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.10% | -7.77% | -6.71% | -1.35% | -10.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.10% | -7.77% | -6.71% | -1.35% | -10.34% |
| Cost of Revenue | -11.98% | -21.67% | -2.52% | 26.70% | -34.42% |
| Gross Profit | 3.32% | 0.46% | -8.52% | -12.11% | 12.26% |
| SG&A Expenses | -19.27% | -12.27% | -24.27% | -12.16% | -17.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.52% | -15.26% | -18.25% | -0.54% | -23.35% |
| Operating Income | 179.75% | 232.30% | 85.02% | -80.78% | 70.99% |
| Income Before Tax | 98.99% | -107.80% | 25.97% | 58.97% | 34.87% |
| Income Tax Expenses | 102.07% | 221.65% | -120.63% | 337.46% | -80.18% |
| Earnings from Continuing Operations | 91.95% | -113.54% | 34.33% | 21.55% | 39.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.95% | -113.54% | 34.33% | 21.55% | 39.69% |
| EBIT | 179.75% | 232.30% | 85.02% | -80.78% | 70.99% |
| EBITDA | 367.64% | 227.40% | 160.33% | -25.52% | 118.32% |
| EPS Basic | 92.15% | -113.17% | 35.72% | 23.42% | 41.04% |
| Normalized Basic EPS | 99.01% | -107.59% | 16.70% | -26.90% | 36.33% |
| EPS Diluted | 91.95% | -169.36% | 32.86% | 23.42% | 42.00% |
| Normalized Diluted EPS | 99.01% | -108.45% | 18.99% | -26.90% | 36.33% |
| Average Basic Shares Outstanding | 2.60% | 2.80% | 2.17% | 2.44% | 2.30% |
| Average Diluted Shares Outstanding | 2.60% | -7.63% | 5.05% | 2.44% | 2.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |